Chemical Component Summary

Name(8alpha)-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide
Identifiers(6~{a}~{R},9~{R})-~{N},~{N}-diethyl-7-methyl-6,6~{a},8,9-tetrahydro-4~{H}-indolo[4,3-fg]quinoline-9-carboxamide
FormulaC20 H25 N3 O
Molecular Weight323.43
TypeNON-POLYMER
Isomeric SMILESCCN(CC)C(=O)[C@H]1CN([C@@H]2Cc3c[nH]c4c3c(ccc4)C2=C1)C
InChIInChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1
InChIKeyVAYOSLLFUXYJDT-RDTXWAMCSA-N

Chemical Details

Formal Charge0
Atom Count49
Chiral Atom Count2
Bond Count52
Aromatic Bond Count10

Drug Info: DrugBank

DrugBank IDDB04829 
NameLysergic acid diethylamide
Groups
  • illicit
  • investigational
  • withdrawn
DescriptionDebate continues over the nature and causes of chronic flashbacks. Explanations in terms of LSD physically remaining in the body for months or years after consumption have been discounted by experimental evidence. Some say HPPD is a manifestation of post-traumatic stress disorder, not related to the direct action of LSD on brain chemistry, and varies according to the susceptibility of the individual to the disorder. Many emotionally intense experiences can lead to flashbacks when a person is reminded acutely of the original experience. However, not all published case reports of chronic flashbacks appear to describe an anxious hyper-vigilant state reminiscent of post-traumatic stress disorder.
Synonyms
  • Diethylamid kyseliny lysergove
  • Lysergsäurediethylamid
  • Lysergide
  • N,N-diethyllysergamide
  • Lysergidum
Categories
  • Agents that produce hypertension
  • Alkaloids
  • Antidepressive Agents
  • Central Nervous System Agents
  • Central Nervous System Depressants
CAS number50-37-3

Drug Targets

NameTarget SequencePharmacological ActionActions
5-hydroxytryptamine receptor 1AMDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCA...unknown
5-hydroxytryptamine receptor 2BMALSYRVSELQSTIPEHILQSTFVHVISSNWSGLQTESIPEEMKQIVEEQ...unknownagonist
5-hydroxytryptamine receptor 6MVPEPGPTANSTPAWGAGPPSAPGGSGWVAAALCVVIALTAAANSLLIAL...unknown
Cytochrome P450 3A4MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...unknownsubstrate
Cytochrome P450 2D6MGLEALVPLAVIVAIFLLLVDLMHRRQRWAARYPPGPLPLPGLGNLLHVD...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDLSDIBZ01
PubChem5761
ChEBICHEBI:6605
ChEMBLCHEMBL263881
PharosCHEMBL263881